Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

518.36 +5.97 (+1.17%)

Streaming Delayed Price Updated: 11:18 AM EDT, Apr 27, 2026 Add to My Watchlist

Price and Volume

Volume	62,503
Open	510.88
Bid (Size)	517.29 (80)
Ask (Size)	519.94 (40)
Prev. Close	512.39
Today's Range	508.51 - 520.67
52wk Range	265.00 - 615.00
Shares Outstanding	17,103,395
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist ↗

April 16, 2026

These companies boast significant upside potential.

Via The Motley Fool

Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now ↗

March 25, 2026

The next 10 months might be challenging for this biotech.

Via The Motley Fool

Performance

YTD	-12.7%	-12.7%
1 Month	+1.5%	+1.5%
3 Month	+3.8%	+3.8%
6 Month	+18.9%	+18.9%
1 Year	+56.5%	+56.5%

More News

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story ↗

March 21, 2026

Via The Motley Fool

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Reports Q4 2025 Revenue Beat and Significant EPS Miss ↗

February 19, 2026

Via Chartmill

Madrigal Doubles Down On MASH With A $4.4 Billion Licensing Deal With China’s Ribo ↗

February 11, 2026

Via Stocktwits

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗

March 21, 2026

Via The Motley Fool

This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund ↗

March 20, 2026

Via The Motley Fool

2 Under-the-Radar Stocks to Buy and Hold ↗

March 10, 2026

Via The Motley Fool

Madrigal (MDGL) Q4 2025 Earnings Call Transcript ↗

February 23, 2026

Via The Motley Fool

Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year ↗

February 23, 2026

Via The Motley Fool

This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50% ↗

February 23, 2026

Via The Motley Fool

Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗

February 17, 2026

Via The Motley Fool

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗

February 17, 2026

Via The Motley Fool

Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗

February 17, 2026

Via The Motley Fool

Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗

February 17, 2026

Via The Motley Fool

Why Madrigal Pharmaceuticals Stock Slumped on Tuesday ↗

January 06, 2026

Via The Motley Fool

Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead ↗

January 05, 2026

Via The Motley Fool

2 Tailwinds Behind Novo Nordisk Stock Heading Into 2026 ↗

January 03, 2026

Via The Motley Fool

2 Predictions for Novo Nordisk in 2026 ↗

December 14, 2025

Via The Motley Fool

2 Stocks Up Over 600% in the Past 3 Years With More Room to Run ↗

December 09, 2025

Via The Motley Fool

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗

December 03, 2025

Via The Motley Fool

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗

November 28, 2025

Via The Motley Fool

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗

November 27, 2025

Via The Motley Fool

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗

November 27, 2025

Via The Motley Fool

Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year ↗

November 27, 2025

Via The Motley Fool

Frequently Asked Questions

Is Madrigal Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Madrigal Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Madrigal Pharmaceuticals, Inc. - Common Stock trade on?

Madrigal Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock is MDGL on the Nasdaq Stock Market

What is the current price of Madrigal Pharmaceuticals, Inc. - Common Stock?

The current price of Madrigal Pharmaceuticals, Inc. - Common Stock is 518.36

When was Madrigal Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Madrigal Pharmaceuticals, Inc. - Common Stock was at 04/27/26 11:18 AM ET

What is the market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock is 8.87B

How many shares of Madrigal Pharmaceuticals, Inc. - Common Stock are outstanding?

Madrigal Pharmaceuticals, Inc. - Common Stock has 9B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.